Thermo Fisher Scientific Phospho-Chk1 (Ser317) Recombinant Rabbit Monoclonal Antibody (Chk1S317-G1), PE
PE 형광 표지된 Phospho-Chk1 (Ser317) 항체로 인간 및 마우스 시료에 반응합니다. 재조합 토끼 단클론 항체로 높은 특이성과 일관성을 제공합니다. Flow Cytometry에 적합하며, 단백질 A/G로 정제되었습니다. 4°C에서 보관합니다.
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Phospho-Chk1 (Ser317) Recombinant Rabbit Monoclonal Antibody (Chk1S317-G1), PE
Applications
Flow Cytometry (Flow)
- Tested Dilution: 5 µL / 1×10⁶ cells
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human, Mouse |
| Host / Isotype | Rabbit / IgG, kappa |
| Expression System | HEK293 cells |
| Class | Recombinant Monoclonal |
| Type | Antibody |
| Clone | Chk1S317-G1 |
| Immunogen | A synthetic phospho-peptide corresponding to residues surrounding Ser317 of human phospho Chk1 |
| Conjugate | PE (R-Phycoerythrin) |
| Excitation / Emission Max | 565 / 576 nm |
| Form | Liquid |
| Purification | Protein A/G |
| Storage Buffer | PBS, pH 7.4, with 0.2% BSA |
| Contains | 0.09% sodium azide |
| Storage Conditions | 4°C |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
| RRID | AB_2897001 |
Additional Formats
- Unconjugated (Cat. MA5-37065)
- APC (Cat. MA5-37068)
- FITC (Cat. MA5-37067)
- Custom conjugation available upon request
Product Specific Information
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems by cloning specific antibody DNA sequences from immunoreactive rabbits. Individual clones are screened to select the best candidates for production.
Advantages:
- High specificity and sensitivity
- Lot-to-lot consistency
- Animal origin-free formulation
- Broad immunoreactivity due to large rabbit immune repertoire
Target Information
CHEK1 (CHK1) is a serine/threonine protein kinase involved in maintaining DNA integrity by preventing replication when DNA damage occurs. It plays a key role in the DNA damage-induced checkpoint network and ensures genomic stability under genotoxic stress.
When CHK1 function is inhibited, p53-deficient cancer cells undergo mitotic catastrophe and apoptosis, while normal cells remain arrested in G1 phase. Therefore, CHK1 is considered an attractive therapeutic target for cancer treatment, particularly in p53-deficient tumors.
For Research Use Only.
Not for use in diagnostic procedures.
Not for resale without express authorization.
제품 이미지
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.